Skip to main content

Table 2 Baseline demographic and clinical data, including hypermobility and symptom scores

From: The effectiveness of a multidisciplinary intervention strategy for the treatment of symptomatic joint hypermobility in childhood: a randomised, single Centre parallel group trial (The Bendy Study)

Characteristics Intervention
(n = 59)
Standard care
(n = 60)
Gender: male, n (%) 27.0 (45.8) 27.0 (45.0)
Age in years, mean (SD) 9.47 (3.18) 9.35 (3.20)
BMI, mean (SD) 18.9 (4.54) 18.0 (2.92)
Family history of JHS, n (%) 11 (18.6) 17.0 (28.3)
Child’s pain assessment, mean (SD) 2.19 (1.36) 2.53 (1.63)
Parent’s pain assessment, mean (SD) 33.8 (24.8) 40.6 (27.5)
Parent’s reported physical function, mean (SD) 0.84 (0.620) 0.860 (0.72)
Child reported HRQoL, mean (SD) 0.85 (0.100) 0.850 (0.12)
Coordination, mean centile (SD) 33.4 (26.7) 35.6 (30.1)
Grip strength (kilopascals), mean (SD) 57.0 (25.0) 59.4 (31.7)
Beighton, mean (SD) 5.80 (1.50) 5.70 (1.40)
Bulbena, mean (SD) 7.40 (1.60) 7.70 (1.30)
Number of painful joints, mean (SD) 1.80 (2.1) 2.10 (2.50)
Participation in sport (number of sessions per week), mean (SD) 2.60 (2.30) 2.60 (2.40)
Absence from school due to MSK problem (individual instances in last 3 months), mean (SD) 1.10 (3.30) 0.630 (2.10)
GP attendance for MSK problem (individual instances in last 3 months), mean (SD) 0.320 (0.800) 0.380 (0.880)
Hospital attendance due to MSK problem (individual instances in last 3 months), mean (SD) 1.10 (0.800) 1.47 (1.41)